Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole ...
Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
On April 13, 2023, the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine will convene a virtual, public workshop to explore the state of the science with ...
Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...
Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...
Improving equitable access to genomics-based clinical trials remains a critical priority in cancer care, according to Dr.
Cancer genomics has revolutionised our understanding of tumour biology by deciphering the complex genetic alterations that underpin oncogenesis. Central to this field is the identification and ...
A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...
LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough ...
FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients eligible for targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results